Metabolic syndrome is associated with learning and recall impairment in middle age

Dementia and Geriatric Cognitive Disorders

Volumn 29, Issue 4, 2010, Pages 356-362

  Hassenstab, Jason J ^a   Sweat, Victoria ^a   Bruehl, Hannah ^a   Convit, Antonio ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Cognitive functioning; Cognitive impairment; Diabetes; Glucose tolerance; Insulin resistance; Memory; Metabolic syndrome; Type 2

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; INTELLECTUAL IMPAIRMENT; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RECALL IMPAIRMENT;

ADULT; AGE FACTORS; AGED; COGNITION; DIABETES MELLITUS, TYPE 2; EXECUTIVE FUNCTION; FEMALE; HUMANS; INSULIN RESISTANCE; LEARNING; MALE; MENTAL RECALL; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 77951245182     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000296071     Document Type: Article

References (38)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371: 1927-1935.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P: Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 2009; 32: 169-174.
5. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N: Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007; 55: 758-762.
6. Ho RC, Niti M, Yap KB, Kua EH, Ng TP: Metabolic syndrome and cognitive decline in Chinese older adults: results from the Singapore longitudinal ageing studies. Am J Geriatr Psychiatry 2008; 16: 519-522.
7. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
8. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30: 2655-2660.
9. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R: Metabolic syndrome and cognitive function: a population-based followup study in elderly women. Dement Geriatr Cogn Disord 2007; 23: 29-34.
10. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
11. Grundy SM: Does the metabolic syndrome exist? Diabetes Care 2006; 29: 1689-1692.
12. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A: Modifiers of cognitive function and brain structure in middleaged and elderly individuals with type 2 diabetes mellitus. Brain Res 2009; 1280: 186-194.
13. Sesti G: Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab 2006; 20: 665-679.
14. Bruehl H, Sweat V, Hassenstab J, Polyakov V, Convit A: Cognitive impairment in non-diabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol, in press.
15. Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS: Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond) 2008; 32(suppl 2):S21-S24.
16. Lindahl B, Asplund K, Hallmans G: High serum insulin, insulin resistance and their associations with cardiovascular risk factors: the northern Sweden MONICA population study. J Intern Med 1993; 234: 263-270.
17. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD: Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-5464.
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
19. Cockrell JR, Folstein MF: Mini-Mental State Examination (MMSE). Psychopharmacol Bull 1988; 24: 689-692.
20. Spreen O, Strauss E: A Compendium of Neuropsychological Tests. Administration, Norms and Commentary. New York, Oxford University Press, 1998.
21. Wechsler D: Wechsler Memory Scale-Revised. San Antonio, Psychological Corporation/ Harcourt Brace Jovanovich, 1987.
22. Wechsler D: Wechsler Adult Intelligence Scale-Revised. New York, Harcourt Brace Jovanovich, 1981.
23. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test. Research Edition. New York, Psychological Corporation, 1987.
24. Cohen J: A power primer. Psychol Bull 1992; 112: 155-159.
25. Kimura D: Sex differences in the brain. Sci Am 1992; 267: 118-125.
26. Kim MH, Kim MK, Choi BY, Shin YJ: Educational disparities in the metabolic syndrome in a rapidly changing society: the case of South Korea. Int J Epidemiol 2005; 34: 1266-1273.
27. Langenberg C, Kuh D, Wadsworth ME, Brunner E, Hardy R: Social circumstances and education: life course origins of social inequalities in metabolic risk in a prospective national birth cohort. Am J Public Health 2006; 96: 2216-2221.
28. Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, Tsui W, Richardson S, Javier E, Convit A: Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007; 50: 711-719.
29. Stewart R, Liolitsa D: Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112.
30. Batty GD, Gale CR, Mortensen LH, Langenberg C, Shipley MJ, Deary IJ: Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study. Diabetologia 2008; 51: 436-443.
31. Messier C: Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 2005; 26: 26-30.
32. Awad N, Gagnon M, Messier C: The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044-1080.
33. Tooke JE, Hannemann MM: Adverse endothelial function and the insulin resistance syndrome. J Intern Med 2000; 247: 425-431.
34. Vinik AI, Erbas T, Park TS, Stansberry KB, Scanelli JA, Pittenger GL: Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 2001; 24: 1468-1475.
35. Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI: Impaired peripheral vasomotion in diabetes. Diabetes Care 1996; 19: 715-721.
36. Convit A: Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 2005; 26: 31-35.
37. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
38. Peppa M, Uribarri J, Vlassara H: The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep 2004; 4: 31-36.